Literature DB >> 3292323

Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps.

D T Finegood1, R N Bergman, M Vranic.   

Abstract

We previously demonstrated that conventional tracer methods applied to euglycemic-hyperinsulinemic glucose clamps result in substantially negative estimates for the rate of endogenous glucose production, particularly during the first half of 180-min clamps. We also showed that addition of tracer to the exogenous glucose infusate resulted in nonnegative endogenous glucose production (Ra) estimates. In this study, we investigated the underlying cause of negative estimates of Ra from conventional clamp/tracer methods and the reason for the difference in estimates when tracer is added to the exogenous glucose infusate. We performed euglycemic-hyperinsulinemic (300-microU/ml) clamps in normal dogs without (cold GINF protocol, n = 6) or with (hot GINF protocol, n = 6) tracer (D-[3-3H]glucose) added to the exogenous glucose infusate. In the hot GINF protocol, sufficient tracer was added to the exogenous glucose infusate such that arterial plasma specific activity (SAa) did not change from basal through the clamp period (P greater than .05). In the cold GINF studies, plasma SAa fell 81 +/- 2% from the basal level by the 3rd h of clamping. We observed a significant, transient, positive venous-arterial difference in specific activity (SAv-SAa difference) during the cold GINF studies. The SAv-SAa difference reached a peak of 27 +/- 6% at 30 min and diminished to a plateau of 7 +/- 1% between 70 and 180 min. We also observed a positive but constant SAv-SAa difference (4.6 +/- 0.2% between 10 and 180 min) during the hot GINF studies. The observations of a difference between hot and cold GINF endogenous Ra estimates and a positive but transient SAv-SAa difference during the cold GINF studies are consistent with the interpretation that a portion of the underestimation of Ra is due to insufficient mixing of endogenous and exogenous glucose for the one-compartment, fixed-pool volume model to be applicable. Alternatively, our results suggest that the one-compartment, fixed-pool volume model of glucose kinetics is insufficient to account for the complex dynamics of labeled and unlabeled glucose during euglycemic-hyperinsulinemic clamps. Improved mixing through addition of tracer to the exogenous glucose infusate or improved modeling by allowing for a variable-pool volume appears to improve the accuracy of the tracer methods; however, these approaches remain to be validated. The constant positive SAv-SAa difference observed during the hot GINF studies is consistent with the interpretation that an additional contributor to underestimation of endogenous Ra is apparent isotope discrimination.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292323     DOI: 10.2337/diab.37.8.1025

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

Review 1.  Is hepatic glucose production increased in type 2 diabetes mellitus?

Authors:  Henning Beck-Nielsen; Ole Hother-Nielsen; Peter Staehr
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 2.  Plasma glucose metabolism during exercise in humans.

Authors:  A R Coggan
Journal:  Sports Med       Date:  1991-02       Impact factor: 11.136

3.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

4.  Beneficial effects of subcutaneous fat transplantation on metabolism.

Authors:  Thien T Tran; Yuji Yamamoto; Stephane Gesta; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

5.  Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.

Authors:  Burak Salgin; Maria L Marcovecchio; Rachel M Williams; Sarah J Jackson; Leslie J Bluck; Sandy M Humphreys; Carlo L Acerini; David B Dunger
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

6.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

7.  Skeletal muscle utilization of free fatty acids in women with visceral obesity.

Authors:  S R Colberg; J A Simoneau; F L Thaete; D E Kelley
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  The set point for maternal glucose homeostasis is lowered during late pregnancy in the rat: the role of the islet beta-cell and liver.

Authors:  C J Nolan; J Proietto
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

9.  Metabolic handling of orally administered glucose in cirrhosis.

Authors:  Y T Kruszynska; A Meyer-Alber; F Darakhshan; P D Home; N McIntyre
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat.

Authors:  C J Nolan; J Proietto
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.